This is unpublished


Professor, Medicine
Adjunct Professor, Health Services, Department of Pharmacy
Director, Hutchinson Institute of Cancer Outcomes Research

Education & Training

  • MD, University of Iowa College of Medicine, Iowa City, IA (1990)
  • Internship and Residency in Internal Medicine, University of Washington, Seattle, WA (1990–1993)
  • PhD, University of Pennsylvania Wharton School, Philadelphia, PA (1994)
  • Chief Residency in Medicine, University of Washington Medical Center, Seattle, WA (1994–1995)
  • Fellowship, General Internal Medicine, Seattle VA Medical Center (1995–1996)


  • Fellow, American College of Physicians (2008)
  • American Society for Clinical Investigation (2006)
  • Howard Temin Career Development Award, National Cancer Institute (1997)
  • Robert Wood Johnson Faculty Support Award (1996)
  • Robert H. Williams Award (1995)
  • Cecile Lehman Mayer Research Award Recipient (1994)
  • General Internal Medicine Fellowship, UW VA (1993–1994)
  • John and Oral Sebelin Award, Outstanding Student in Internal Medicine (1990)
  • University Research Foundation Support Grant (1989)
  • Dean's Scholarship, Wharton School (1987)
  • Kellogg Washington Health Policy Fellowship (1986)
  • University of Iowa Certificate of Achievement (1983)

clinical interests

  • Cancer screening
  • Cancer survivorship


Dr. Scott Ramsey is a general internist and health economist. He is a Professor in the Cancer Prevention Program, Public Health Sciences Division at the Fred Hutchinson Cancer Center, where he directs the Hutchinson Institute for Cancer Outcomes Research, a multidisciplinary team devoted to clinical and economic evaluations of new and existing cancer prevention, screening, and treatment technologies. In addition, Dr. Ramsey is a Professor in the Schools of Medicine and Pharmacy at the University of Washington.

Trained in medicine and economics, Dr. Ramsey’s research focuses on economic evaluations in cancer. He has published widely on patterns of care, costs, and cost-effectiveness of treatments for lung, colorectal, and prostate cancer. His research portfolio and interests include large-scale SEER-Medicare/Cancer Registry data linkages, patient-reported outcomes, economic modeling of health care interventions, cost-effectiveness analysis, quality-of-life assessment, patterns of care, health care utilization, economic burden of disease for patients and society, pragmatic trial design, early technology assessment, and stakeholder engagement.

Publication highlights